Pan-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa
Provided herein are methods and uses of antibodies against ELR+ CXC chemokines for the treatment of hidradenitis suppurativa. Also provided are doses and dosing regimens for the methods and uses of antibodies against ELR+ CXC chemokines for the treatment of hidradenitis suppurativa.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
02.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are methods and uses of antibodies against ELR+ CXC chemokines for the treatment of hidradenitis suppurativa. Also provided are doses and dosing regimens for the methods and uses of antibodies against ELR+ CXC chemokines for the treatment of hidradenitis suppurativa. |
---|---|
Bibliography: | Application Number: AU20190364239 |